F2 and COVID-19: Coagulopathy in COVID-19 differs from the usual disseminated intravascular coagulation, in having a high fibrinogen, normal or mildly prolonged prothrombin time and activated partial thromboplastin time, platelet count >100 × 103/ml, but no significant bleeding (14).